Whipple's Pancreaticoduodenectomy at a Resource-poor, Low-volume Center in Trinidad and Tobago

Overview

Journal World J Clin Oncol

Publisher Baishideng Publishing Group

Specialty Oncology

Date 2022 Oct 10

PMID 36212600

Authors

Shamir O Cawich

Dexter A Thomas

Neil W Pearce

Vijay Naraynsingh

Affiliations

Soon will be listed here.

Abstract

Background: Many authorities advocate for Whipple's procedures to be performed in high-volume centers, but many patients in poor developing nations cannot access these centers. We sought to determine whether clinical outcomes were acceptable when Whipple's procedures were performed in a low-volume, resource-poor setting in the West Indies.

Aim: To study outcomes of Whipple's procedures in a pancreatic unit in the West Indies over an eight-year period from June 1, 2013 to June 30, 2021.

Methods: This was a retrospective study of all patients undergoing Whipple's procedures in a pancreatic unit in the West Indies over an eight-year period from June 1, 2013 to June 30, 2021.

Results: This center performed an average of 11.25 procedures per annum. There were 72 patients in the final study population at a mean age of 60.2 years, with 52.7% having American Society of Anesthesiologists scores ≥ III and 54.1% with Eastern Cooperative Oncology Group scores ≥ 2. Open Whipple's procedures were performed in 70 patients and laparoscopic assisted procedures in 2. Portal vein resection/reconstruction was performed in 19 (26.4%) patients. In patients undergoing open procedures there was 367 ± 54.1 min mean operating time, 1394 ± 656.8 mL mean blood loss, 5.24 ± 7.22 d mean intensive care unit stay and 15.1 ± 9.53 d hospitalization. Six (8.3%) patients experienced minor morbidity, 10 (14%) major morbidity and there were 4 (5.5%) deaths.

Conclusion: This paper adds to the growing body of evidence that volume alone should not be used as a marker of quality for patients requiring Whipple's procedures. Low volume centers in resource poor nations can achieve good short-term outcomes. This is largely due to the process of continuous, adaptive learning by the entire hospital.

References

Riall T, Eschbach K, Townsend Jr C, Nealon W, Freeman J, Goodwin J . Trends and disparities in regionalization of pancreatic resection. J Gastrointest Surg. 2007; 11(10):1242-51. DOI: 10.1007/s11605-007-0245-5. View

McPhee J, Hill J, Whalen G, Zayaruzny M, Litwin D, Sullivan M . Perioperative mortality for pancreatectomy: a national perspective. Ann Surg. 2007; 246(2):246-53. PMC: 1933570. DOI: 10.1097/01.sla.0000259993.17350.3a. View

Eppsteiner R, Csikesz N, McPhee J, Tseng J, Shah S . Surgeon volume impacts hospital mortality for pancreatic resection. Ann Surg. 2009; 249(4):635-40. DOI: 10.1097/SLA.0b013e31819ed958. View

Bliss L, Yang C, Chau Z, Ng S, McFadden D, Kent T . Patient selection and the volume effect in pancreatic surgery: unequal benefits?. HPB (Oxford). 2014; 16(10):899-906. PMC: 4238856. DOI: 10.1111/hpb.12283. View

Van Heek N, Kuhlmann K, Scholten R, de Castro S, Busch O, van Gulik T . Hospital volume and mortality after pancreatic resection: a systematic review and an evaluation of intervention in the Netherlands. Ann Surg. 2005; 242(6):781-8, discussion 788-90. PMC: 1409869. DOI: 10.1097/01.sla.0000188462.00249.36. View

Ihse I . The volume-outcome relationship in cancer surgery: a hard sell. Ann Surg. 2003; 238(6):777-81. PMC: 1356159. DOI: 10.1097/01.sla.0000098616.19622.af. View

Bilimoria K, Bentrem D, Feinglass J, Stewart A, Winchester D, Talamonti M . Directing surgical quality improvement initiatives: comparison of perioperative mortality and long-term survival for cancer surgery. J Clin Oncol. 2008; 26(28):4626-33. DOI: 10.1200/JCO.2007.15.6356. View

Liu J, Zingmond D, McGory M, SooHoo N, Ettner S, Brook R . Disparities in the utilization of high-volume hospitals for complex surgery. JAMA. 2006; 296(16):1973-80. DOI: 10.1001/jama.296.16.1973. View

Al-Refaie W, Muluneh B, Zhong W, Parsons H, Tuttle T, Vickers S . Who receives their complex cancer surgery at low-volume hospitals?. J Am Coll Surg. 2011; 214(1):81-7. DOI: 10.1016/j.jamcollsurg.2011.10.003. View

10.

Mayo S, Gilson M, Herman J, Cameron J, Nathan H, Edil B . Management of patients with pancreatic adenocarcinoma: national trends in patient selection, operative management, and use of adjuvant therapy. J Am Coll Surg. 2011; 214(1):33-45. PMC: 3578342. DOI: 10.1016/j.jamcollsurg.2011.09.022. View

11.

Glasgow R, Mulvihill S . Hospital volume influences outcome in patients undergoing pancreatic resection for cancer. West J Med. 1996; 165(5):294-300. PMC: 1303846. View

12.

Ho V, Heslin M . Effect of hospital volume and experience on in-hospital mortality for pancreaticoduodenectomy. Ann Surg. 2003; 237(4):509-14. PMC: 1514467. DOI: 10.1097/01.SLA.0000059981.13160.97. View

13.

Halloran C, Ghaneh P, Bosonnet L, Hartley M, Sutton R, Neoptolemos J . Complications of pancreatic cancer resection. Dig Surg. 2002; 19(2):138-46. DOI: 10.1159/000052029. View

14.

Schmidt C, Turrini O, Parikh P, House M, Zyromski N, Nakeeb A . Effect of hospital volume, surgeon experience, and surgeon volume on patient outcomes after pancreaticoduodenectomy: a single-institution experience. Arch Surg. 2010; 145(7):634-40. DOI: 10.1001/archsurg.2010.118. View

15.

Hashimoto D, Bababekov Y, Mehtsun W, Stapleton S, Warshaw A, Lillemoe K . Is Annual Volume Enough? The Role of Experience and Specialization on Inpatient Mortality After Hepatectomy. Ann Surg. 2017; 266(4):603-609. PMC: 5881166. DOI: 10.1097/SLA.0000000000002377. View

16.

Kotwall C, Maxwell J, Brinker C, Koch G, Covington D . National estimates of mortality rates for radical pancreaticoduodenectomy in 25,000 patients. Ann Surg Oncol. 2002; 9(9):847-54. DOI: 10.1007/BF02557520. View

17.

Epstein A, Gray B, Schlesinger M . Racial and ethnic differences in the use of high-volume hospitals and surgeons. Arch Surg. 2010; 145(2):179-86. DOI: 10.1001/archsurg.2009.268. View

18.

Teoule P, Bartel F, Birgin E, Ruckert F, Wilhelm T . The Clavien-Dindo Classification in Pancreatic Surgery: A Clinical and Economic Validation. J Invest Surg. 2018; 32(4):314-320. DOI: 10.1080/08941939.2017.1420837. View

19.

Lassen K, Ljungqvist O, Dejong C, Demartines N, Parks R, Lobo D . Pancreaticoduodenectomy: ERAS recommendations. Clin Nutr. 2013; 32(5):870-1. DOI: 10.1016/j.clnu.2013.04.019. View

20.

Ho C, Kleeff J, Friess H, Buchler M . Complications of pancreatic surgery. HPB (Oxford). 2008; 7(2):99-108. PMC: 2023932. DOI: 10.1080/13651820510028936. View